AAN 2021 | Latest advances in functional movement disorders at AAN 2021
Alberto Espay, MD, FAAN, University of Cincinnati, Cincinnati, OH, outlines the topics he will discuss during his presentation on the treatment of functional movement disorders at the American Academy of Neurology virtual meeting 2021. Prof. Espay will talk on the latest therapeutic strategies for functional movement disorders, ongoing clinical trials, and the critical nature of early diagnosis and immediate treatment. This interview took place during the American Academy of Neurology (AAN) 2021 Annual Meeting.
Disclosures
Dr. Espay has received grant support from the NIH and the Michael J Fox Foundation; personal compensation as a consultant/scientific advisory board member for Abbvie, Neuroderm, Neurocrine, Amneal, Acadia, Acorda, Kyowa Kirin, Sunovion, Lundbeck, and USWorldMeds; honoraria from Acadia, Sunovion, Amneal, USWorldMeds; and publishing royalties from Lippincott Williams & Wilkins, Cambridge University Press, and Springer. He cofounded REGAIN Therapeutics, owner of a patent application that covers synthetic soluble non-aggregating peptide analogues as replacement treatment in proteinopathies. He serves on the editorial boards of the Journal of Parkinson’s Disease, European Journal of Neurology, and JAMA Neurology.
